Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

CTSO
Cytosorbents Corp.
stock NASDAQ

At Close
Jul 31, 2026 12:40:43 PM EDT
0.3700USD+4.370%(+0.0153)88,331
0.00Bid   0.00Ask   0.0000Spread
Pre-market
Jul 31, 2026 9:05:30 AM EDT
0.3874USD+10.654%(+0.0373)24,158
After-hours
Jul 31, 2026 4:00:30 PM EDT
0.3609USD-1.232%(-0.0045)1,715
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 24, 2022
08:24AM EST  New Publication Reports Reductions In Bleeding Complications Following Acute Aortic Dissection Surgery Using CTSO' Tech   RTTNews
07:01AM EST  Complications Following Acute Aortic Dissection Surgery using CytoSorbents' Antithrombotic Drug Removal Technology   PR Newswire
Jan 18, 2022
07:08AM EST  CytoSorbents Reports Preliminary 2021 Product Sales About $40.1 Mln, Inclg Core Non-COVID-19 Sales Growth Of 13%   RTTNews
07:03AM EST  CytoSorbents Sees Prelim. Q4 Sales $10.8M vs $9.58M Est.; Sees Prelim. FY21 Sales $43.2M vs $41.95M Est.   Benzinga
07:01AM EST  CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter   PR Newswire
Dec 21, 2021
07:13AM EST  CytoSorbents Appoints Daniel Wendt As VP, Medical Affairs Cardiovascular   RTTNews
07:05AM EST  CytoSorbents Appoints Daniel Wendt, MD, PhD, MHBA, FECTS as Vice President,   PR Newswire
06:37AM EST  Cytosorbents Granted U.S. Patent #11,202,855 ' Methods for removal of toxins from blood using an extracorporeal circuit comprised of a hollow-fiber filter module and polymer sorbent in combination'   Benzinga
Dec 20, 2021
07:14AM EST  CytoSorbents Publishes CTC Multicenter Registry Results Using CytoSorb In Critically Ill COVID-19 Patients On ECMO   RTTNews
07:11AM EST  CytoSorbents Announced Publication of U.S. CTC Multicenter Registry Results Using CytoSorb in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation in Frontiers in Medicine   Benzinga
07:10AM EST  Using CytoSorb(r) in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO)   PR Newswire
Dec 6, 2021
10:24AM EST  CytoSorbents Sponsored Study Titled 'CytOSorb TreatMent Of Critically Ill PatientS Registry' Posted To ClinicalTrials.gov; Study Not Yet Recruiting   Benzinga
Nov 15, 2021
04:31PM EST  Digital Health & Services Forum and Jefferies London Healthcare Conference   PR Newswire
Nov 5, 2021
09:32AM EDT  CytoSorbents Q3 EPS $(0.15) Misses $(0.12) Estimate, Sales $9.76M Miss $11.02M Estimate   Benzinga
Nov 4, 2021
04:16PM EDT  CytoSorbents Reports Full Third Quarter 2021 Financial and Operational Results   PR Newswire
05:00AM EDT  Earnings Scheduled For November 4, 2021   Benzinga
Oct 20, 2021
07:55AM EDT  CytoSorbents Corp. (CTSO), which provides the treatment of life-threatening conditions in intensive care and cardiac surgery using CytoSorb blood purification, made additional comments on the investigator-initiated REMOVE study following the formal presentation of trial results on October 16th at the EACTS annual meeting in Barcelona, Spain.   RTTNews
07:09AM EDT  CytoSorbents : No Signal For Harm Due To Use Of CytoSorb In Patients Undergoing Surgery For Infective Endocarditis   RTTNews
07:06AM EDT  CytoSorbents Comments on REMOVE Study Presentation   PR Newswire
Oct 14, 2021
07:12AM EDT  CytoSorbents : First Patient Enrolled In U.S. STAR-T Trial Evaluating DrugSorb-ATR Antithrombotic Removal System   RTTNews
07:11AM EDT  CytoSorbents Announces First Patient Enrolled In U.S. STAR-T Pivotal Trial Evaluating the DrugSorb-ATR Antithrombotic Removal System To Remove Ticagrelor During Cardiothoracic Surgery   Benzinga
07:05AM EDT  DrugSorb-ATR(tm) Antithrombotic Removal System to Remove Ticagrelor During Cardiothoracic Surgery   PR Newswire
Oct 13, 2021
01:38PM EDT  The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal   Benzinga
06:43AM EDT  The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 06.15 A.M. EDT).   RTTNews
Oct 12, 2021
04:39PM EDT  CytoSorbents Receives Full FDA Investigational Device Exemption Approval To Begin US STAR-D Trial On Apixaban And Rivaroxaban Removal By DrugSorb-ATR Antithrombotic Removal System During Urgent Cardiothoracic Surgery   Benzinga
04:38PM EDT  to Begin U.S. STAR-D Trial on Apixaban and Rivaroxaban Removal by the DrugSorb-ATR(tm) Antithrombotic Removal System During Urgent Cardiothoracic Surgery   PR Newswire
04:38PM EDT  CytoSorbents Sees Q3 2021 Revenues $9.7M Vs $11.96M Est   Benzinga
04:35PM EDT  CytoSorbents Provides Preliminary Third Quarter Business Update and Revised   PR Newswire
Oct 7, 2021
03:12PM EDT  Endocarditis Studies, including the REMOVE study, to be Presented at the EACTS Conference   PR Newswire
Sep 14, 2021
09:25AM EDT  CytoSorbents to Host International Webinar on the Worldwide Experience Using   PR Newswire
Sep 13, 2021
07:08AM EDT  CytoSorbents Commemorates World Sepsis Day and Sepsis Awareness Month with Key   PR Newswire
Sep 10, 2021
07:16AM EDT  CytoSorbents Announces Filing Of IDE Application To Gain FDA Approval To Conduct Clinical Study, STAR-D   RTTNews
07:13AM EDT  CytoSorbents Announces Filing Of Investigational Device Exemption For US Clinical Trial On Apixaban And Rivaroxaban Removal By DrugSorb-ATR Antithrombotic Removal System During Urgent Cardiothoracic Surgery   Benzinga
07:08AM EDT  the U.S. Clinical Trial on Apixaban and Rivaroxaban Removal by the DrugSorb-ATR(tm) Antithrombotic Removal System During Urgent Cardiothoracic Surgery   PR Newswire
Sep 8, 2021
04:16PM EDT  Registry using CytoSorb(r) in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO)   PR Newswire
Sep 1, 2021
09:53AM EDT  CytoSorbents shares were trading higher after the company announced topline results from its US CTC multicenter registry demonstrate high survival using CytoSorb in critically ill COVID-19 patients on membrane oxygenation.   Benzinga
08:36AM EDT  CytoSorbents Corporation (CTSO) on Wednesday announced topline CTC (CytoSorb Therapy in COVID-19) Registry results showing high survival rate in critically ill COVID-19 patients on Extracorporeal Membrane Oxygenation (ECMO) treated with CytoSorb.   RTTNews
07:13AM EDT  CytoSorbents Presents Topline Results From CytoSorb Therapy In COVID-19 Multicenter Registry At ISICEM 2021   RTTNews
07:10AM EDT  Topline Results From CytoSorbents' U.S. CTC Multicenter Registry Demonstrate High Survival Using CytoSorb In Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation   Benzinga
07:08AM EDT  High Survival using CytoSorb(r) in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO)   PR Newswire
Aug 30, 2021
07:10AM EDT  CytoSorbents, Aferetica Unveil Launch Of PerSorb Adsorber And PerLife Organ Perfusion System In Italy   RTTNews
07:10AM EDT  CytoSorbents Launches PerSorb Adsorber and PerLife Products in Italy   Benzinga
07:08AM EDT  PerSorb(tm) Adsorber and PerLife(tm) Organ Perfusion System, respectively, at the European Society of Organ Transplantation Congress   PR Newswire
Aug 20, 2021
01:44PM EDT  Looking into CytoSorbents's Return on Capital Employed   Benzinga
Aug 12, 2021
07:15AM EDT  CytoSorbents: FDA Grants Second Breakthrough Device Designation For DrugSorb-ATR Antithrombotic Removal System   RTTNews
07:09AM EDT  Second U.S. FDA Breakthrough Device Designation Granted to CytoSorbents' DrugSorb-ATR Antithrombotic Removal System Adding the Removal of Market-Leading Direct Oral Anticoagulants During Urgent Cardiothoracic Surgery   Benzinga
07:03AM EDT  DrugSorb-ATR(tm) Antithrombotic Removal System Adding the Removal of Market-Leading Direct Oral Anticoagulants During Urgent Cardiothoracic Surgery   PR Newswire
Aug 6, 2021
07:42AM EDT  The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO   Benzinga
Aug 5, 2021
08:08AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO   Benzinga
Aug 4, 2021
07:00AM EDT  CytoSorbents Q2 Earnings Lag Consensus, Higher Costs Weigh On Bottom Line   Benzinga
Aug 3, 2021
05:15PM EDT  CytoSorbents Expects H1 2021 Product Sales Less Than $1M   Benzinga
05:14PM EDT  CytoSorbents Q2 EPS $(0.11) Misses $(0.04) Estimate, Sales $12.00M Miss $12.27M Estimate   Benzinga
04:16PM EDT  CytoSorbents Reports Second Quarter 2021 Financial and Operational Results   PR Newswire
07:55AM EDT  The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business   Benzinga
03:52AM EDT  Earnings Scheduled For August 3, 2021   Benzinga
Aug 1, 2021
11:19AM EDT  The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs   Benzinga
Jul 30, 2021
07:08AM EDT  CytoSorbents Completes its Mission 100,000 International Fundraising Campaign   PR Newswire
Jul 26, 2021
12:39PM EDT  CytoSorbents Sponsored Study Titled 'Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T) (STAR-T)' Posted To ClinicalTrials.Gov; Study Not Yet Recruiting   Benzinga
Jul 19, 2021
07:08AM EDT  CytoSorbents to Report Second Quarter 2021 Operating and Financial Results   PR Newswire
Jul 6, 2021
08:12AM EDT  CytoSorbents Shares Are Trading Higher On Launch Of Trial On Ticagrelor Removal During Cardiothoracic Surgery   Benzinga
07:13AM EDT  CytoSorbents Receives Full FDA Approval of Investigational Device Exemption For U.S. STAR-T Trial on Ticagrelor Removal During Cardiothoracic Surgery   Benzinga
07:06AM EDT  CytoSorbents Receives Full FDA Approval Of Investigational Device Exemption (IDE) For U.S. STAR-T Trial   RTTNews
07:05AM EDT  (IDE) for U.S. STAR-T Trial on Ticagrelor Removal During Cardiothoracic Surgery   PR Newswire
Jun 1, 2021
07:16AM EDT  CytoSorbents Appoints Terri Anne Powers As VP Of Investor Relations And Corporate Communications   RTTNews
07:08AM EDT  CytoSorbents Appoints Terri Anne Powers, IRC as Vice President of Investor   PR Newswire
May 27, 2021
07:01AM EDT  CytoSorbents to Present at the Jefferies Virtual Healthcare Conference   PR Newswire
May 25, 2021
07:08AM EDT  CytoSorb(r) Registered and Commercially Available in Singapore   PR Newswire
May 19, 2021
07:01AM EDT  CytoSorbents to Present at the UBS Global Healthcare Virtual Conference and   PR Newswire
May 11, 2021
08:50AM EDT  CytoSorbents Awarded $1.5 Million Sequential Phase II SBIR Contract to Advance   PR Newswire
May 5, 2021
07:43AM EDT  The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues   Benzinga
May 4, 2021
05:04PM EDT  CytoSorbents Q1 EPS $(0.10) Misses $(0.03) Estimate, Sales $10.14M Miss $11.50M Estimate   Benzinga
04:16PM EDT  CytoSorbents Reports First Quarter 2021 Financial and Operational Results   PR Newswire
08:10AM EDT  The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data   Benzinga
Apr 27, 2021
01:56PM EDT  CytoSorbents to Report Q1 2021 Operating and Financial Results   PR Newswire
Apr 19, 2021
12:24PM EDT  CytoSorbents To Start US Study With CytoSorb For Ticagrelor Removal   Benzinga
07:20AM EDT  FDA Approves CytoSorbents To Initiate US STAR-T Trial For Ticagrelor Removal During Cardiothoracic Surgery   Benzinga
07:08AM EDT  U.S. FDA Approves CytoSorbents to Initiate U.S. STAR-T Trial For Ticagrelor   PR Newswire
Mar 29, 2021
07:14AM EDT  CytoSorbents Announces Lease Of Its New Global Headquarters In Princeton, NJ   RTTNews
07:13AM EDT  CytoSorbents Announces Lease Of New Global Headquarters In Princeton, New Jersey   Benzinga
Mar 16, 2021
03:17PM EDT  CytoSorbents Announces Filing Of An Investigational Device Exemption For US Trial On Ticagrelor Removal During Cardiothoracic Surgery   Benzinga
03:15PM EDT  CytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for   PR Newswire
Mar 12, 2021
07:01AM EST  CytoSorbents to Present at the Oppenheimer 31st Annual Healthcare Conference   PR Newswire
Mar 9, 2021
04:29PM EST  CytoSorbents: Q4 Earnings Insights   Benzinga
04:17PM EST  CytoSorbents Says 'we expect our first quarter 2021 product sales will exceed product sales reported in the first quarter of 2020'   Benzinga
04:17PM EST  CytoSorbents Q4 EPS $(0.20) Misses $(0.04) Estimate, Sales $12.00M Beat $10.95M Estimate   Benzinga
04:16PM EST  CytoSorbents Announces 2020 Financial and Operational Results   PR Newswire
09:17AM EST  The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data   Benzinga
04:09AM EST  Earnings Scheduled For March 9, 2021   Benzinga
Mar 8, 2021
10:10AM EST  CytoSorbents's Earnings Outlook   Benzinga
Mar 6, 2021
10:58AM EST  The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings   Benzinga
Mar 2, 2021
07:04AM EST  B. Braun Avitum AG And CytoSorbents Announce Global Joint-Marketing Agreement To Promote Use Of CytoSorb With B. Braun's OMNI Platform   Benzinga
07:02AM EST  Agreement to Promote the OMNI(r) Continuous Blood Purification Platform with CytoSorb(r)   PR Newswire
Mar 1, 2021
06:01PM EST  CytoSorbents to Report Fiscal 2020 Operating and Financial Results   PR Newswire
Feb 24, 2021
07:08AM EST  CytoSorbents to Present at the Cowen 41st Annual Health Care Conference   PR Newswire
Feb 18, 2021
07:08AM EST  CytoSorbents 2021: Leadership and Growth in the "New Normal"   PR Newswire
Feb 16, 2021
07:08AM EST  CytoSorbents to Present at the 10th Annual SVB Leerink Global Healthcare   PR Newswire
Feb 4, 2021
07:27AM EST  CytoSorbents Says National Institute For Health And Care Excellence Issues Medtech Innovation Briefing On Co For 'Reducing Risk Of Bleeding During Cardiac Surgery'   Benzinga
07:08AM EST  Innovation Briefing on CytoSorb for Reducing Risk of Bleeding During Cardiac Surgery   PR Newswire
Jan 21, 2021
07:08AM EST  CytoSorbents Appoints David D. Cox, PhD, MBA as Vice President - Global   PR Newswire
Jan 19, 2021
07:10AM EST  CytoSorbents Reports Approval Of CytoSorb In Korea In Collaboration With Partner Fresenius Medical Care   RTTNews
07:08AM EST  CytoSorbents Announces Approval of CytoSorb(r) in Korea in Collaboration with   PR Newswire
Jan 12, 2021
07:06AM EST  CytoSorbents Reports Q4 Preliminary Product Sales Of $11.5 Mln   RTTNews
07:01AM EST  Health Canada Authorizes CytoSorb for Use in Hospitalized COVID-19 Patients   PR Newswire
07:00AM EST  CytoSorbents Reports Q4 Prelim. Sales of $11.8M Up From $7.4M YoY   Benzinga
06:58AM EST  CytoSorbents Reports Preliminary Fourth Quarter and Full Year 2020 Revenue   PR Newswire
Jan 11, 2021
06:01AM EST  CytoSorbents Appoints James Komsa As VP- U.S. Sales And Marketing   RTTNews
06:01AM EST  CytoSorbents Appoints James Komsa as Vice President - U.S. Sales and Marketing   PR Newswire
Jan 4, 2021
06:56AM EST  CytoSorbents Corp. (CTSO), which commercializes its CytoSorb blood purification technology that treats deadly inflammation in critically ill and cardiac surgery patients around the world, said that Health Canada has granted Medical Device Authorization for the importation, sale, and emergency use of CytoSorb in hospitalized COVID-19 patients.   RTTNews
06:41AM EST  Health Canada Grants Medical Device Authorization ForCytoSorb In Hospitalized COVID-19 Patients   RTTNews
06:30AM EST  Health Canada Authorizes CytoSorb for Use in Hospitalized COVID-19 Patients   PR Newswire
Dec 17, 2020
07:12AM EST  CytoSorbents Announces Promotion Of Christian Steiner To EVP - Sales And Marketing   RTTNews
07:08AM EST  CytoSorbents Promotes Dr. Christian Steiner to Executive Vice President of   PR Newswire
Dec 10, 2020
07:01AM EST  CytoSorbents Pays Off $15M Term Loans and Establishes New Undrawn $15M Loan   PR Newswire
Dec 9, 2020
06:45AM EST  Early CytoSorb Initiation Improves Hemodynamic Stabilization and Survival in   PR Newswire
Dec 2, 2020
07:08AM EST  CytoSorbents Launches International Campaign to Raise $100,000 for the Global   PR Newswire
Nov 25, 2020
07:09AM EST  CytoSorbents Highlights Published Case Series To Date Using CytoSorb In Critically Ill COVID-19 Patients   RTTNews
07:08AM EST  CytoSorbents Highlights Largest Published Case Series To Date Using CytoSorb in   PR Newswire
Nov 23, 2020
07:01AM EST  CytoSorbents to Present at the Piper Sandler 32nd Annual Healthcare Conference   PR Newswire
Nov 12, 2020
02:01AM EST  CytoSorbents to Present at the Jefferies Virtual London Healthcare Conference   PR Newswire
Nov 5, 2020
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
Nov 4, 2020
04:48PM EST  CytoSorbents: Q3 Earnings Insights   Benzinga
04:44PM EST  CytoSorbents Q3 EPS $(0.02) Beats $(0.09) Estimate, Sales $10.55M Beat $9.51M Estimate   Benzinga
04:16PM EST  CytoSorbents Reports Record Third Quarter 2020 Financial Results   PR Newswire
08:21AM EST  The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings   Benzinga
04:41AM EST  Earnings Scheduled For November 4, 2020   Benzinga
Nov 3, 2020
10:08AM EST  Earnings Outlook for CytoSorbents   Benzinga
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 21, 2020
07:08AM EDT  CytoSorbents to Report Q3 2020 Operating and Financial Results   PR Newswire
Oct 14, 2020
07:07AM EDT  CytoSorbents And Aferetica Announce European Union Approval Of The PerLife System And ECOS-300CY PerSorb Cartridge For Combined Perfusion And Purification Of Solid Organs Dedicated To Transplant   Benzinga
07:01AM EDT  System and ECOS-300CY(tm) PerSorb(tm) Cartridge for Combined Perfusion and Purification of Solid Organs Dedicated to Transplant   PR Newswire
Oct 9, 2020
07:08AM EDT  The U.S. Department of Defense Awards $1.1M to CytoSorbents to Optimize Development of HemoDefend-BGA for Life-saving Universal Plasma   Benzinga
07:08AM EDT  The U.S. Department of Defense Awards $1.1 Million to CytoSorbents to Optimize   PR Newswire
Sep 21, 2020
07:17AM EDT  CytoSorbents Says CytoSorb Is Now Commercially Available To Treat Cytokine Storm In COVID-19 Infection   RTTNews
07:08AM EDT  CytoSorb Achieves Registration in Brazil and Is Now Commercially Available To   PR Newswire
Sep 17, 2020
05:39AM EDT  Jefferies Initiates Coverage On CytoSorbents with Buy Rating, Announces Price Target of $15   Benzinga
Sep 11, 2020
08:01AM EDT  CytoSorbents Highlights CytoSorb Use in Sepsis Patients During Sepsis Awareness   PR Newswire
Sep 8, 2020
07:13AM EDT  CytoSorbents Announces 'CytoSorb Therapy in COVID-19 ICU Patients' (CTC) Registry Is Actively Enrolling   Benzinga
07:12AM EDT  CytoSorbents Says CytoSorb Therapy In COVID-19 ICU Patients Registry Is Now Live And Actively Enrolling Patients   RTTNews
07:08AM EDT  CytoSorbents Announces the "CytoSorb Therapy in COVID-19 ICU Patients" (CTC)   PR Newswire
Sep 1, 2020
09:47AM EDT  Benzinga's Top Upgrades, Downgrades For September 1, 2020   Benzinga
Aug 24, 2020
07:02AM EDT  Terumo Cardiovascular And CytoSorbents Collaborate To Commercialize CytoSorb In Ten US Hotspot States Under Emergency Use Authorization For COVID-19   Benzinga
07:01AM EDT  Terumo Cardiovascular and CytoSorbents Collaborate to Commercialize CytoSorb(r)   PR Newswire
Aug 17, 2020
07:20AM EDT  CytoSorbents Enters Separate Agreements With InvoSurg And Surgical Partners To Commercialize CytoSorb   RTTNews
07:10AM EDT  CytoSorbents Partners With InvoSurg And Surgical Partners To Commercialize CytoSorb In US Northeast, Mid-Atlantic, And Florida Under FDA Emergency Use Authorization For COVID-19   Benzinga
07:08AM EDT  CytoSorb(r) in the U.S. Northeast, Mid-Atlantic, and Florida under FDA Emergency Use Authorization for COVID-19   PR Newswire
Aug 4, 2020
05:19PM EDT  Recap: CytoSorbents Q2 Earnings   Benzinga
04:47PM EDT  CytoSorbents Q2 EPS $(0.08), Inline, Sales $9.79M Beat $9.66M Estimate   Benzinga
04:16PM EDT  CytoSorbents Reports Record Second Quarter 2020 Financial Results   PR Newswire
05:19AM EDT  Earnings Scheduled For August 4, 2020   Benzinga
Aug 3, 2020
12:47PM EDT  Earnings Outlook for CytoSorbents   Benzinga
07:02AM EDT  CytoSorbents Achieves Milestone of More than 100,000 CytoSorb Treatments   PR Newswire
Jul 31, 2020
07:27AM EDT  CytoSorbents Bags $4.4 Mln Contract From DoD To Complete HemoDefend-BGA Adsorber Preclinical Development   RTTNews
07:10AM EDT  CytoSorbents Awarded $4.4M Contract By US Department Of Defense To Complete HemoDefend-BGA Adsorber Preclinical Development   Benzinga
07:08AM EDT  CytoSorbents Awarded $4.4 Million Contract by the U.S. Department of Defense to   PR Newswire
Jul 28, 2020
07:16AM EDT  CytoSorbents Announces the REFRESH 2-AKI Trial Data Monitoring Committee Has Recommended Study Resumption Following Favorable Review Of Safety Data   Benzinga
07:08AM EDT  CytoSorbents Announces the REFRESH 2-AKI Trial Data Monitoring Committee Has   PR Newswire
06:01AM EDT  CytoSorbents to Report Q2 2020 Operating and Financial Results   PR Newswire
Jul 22, 2020
10:53AM EDT  Shares of Cytosorbents Corporation (CTSO), a critical care immunotherapy company specialized in blood purification technology, are up more than 10% Wednesday morning at $10.76, close to its 52-week high of $11.74.   RTTNews
07:25AM EDT  CytoSorbents Prices ~5.263M Share Common Stock Offering At $9.50/Share   Benzinga
07:24AM EDT  CytoSorbents Reports Pricing Of $50 Mln Public Offering Of Common Stock   RTTNews
07:22AM EDT  CytoSorbents Corporation Announces Pricing of $50 Million Public Offering of   PR Newswire
Jul 21, 2020
10:13AM EDT  Mid-Morning Market Update: Markets Mostly Higher; Coca-Cola Earnings Beat Views   Benzinga
Jul 20, 2020
04:53PM EDT  CytoSorbents Sees Prelim. Q2 Sales $9.8M vs $9.25M Est.   Benzinga
04:52PM EDT  CytoSorbents Provides Preliminary Q2 2020 Financial Results and Corporate Update   PR Newswire
04:28PM EDT  CytoSorbents Corp Announces A Proposed $40 Million Common Stock Offering   Benzinga
04:27PM EDT  CytoSorbents Corporation Announces Proposed $40 Million Public Offering of   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC